ARTICLE | Distillery Therapeutics
Neurology
November 14, 2017 10:59 PM UTC
Cell culture and mouse studies suggest inhibiting proteolytic processing of CDK5R1 into its truncated form could help treat frontotemporal dementia (FTD). In FTD patient-derived cerebral organoids, kn...
BCIQ Company Profiles